Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

838
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
838
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer02:18

Cancer

55.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.8K
Tumor Progression02:07

Tumor Progression

7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.

JCO precision oncology·2026
Same author

Archetype analysis of lung adenocarcinoma premalignancy links heterogeneity in premalignant lesions to diverging features of invasive disease.

Molecular cancer research : MCR·2026
Same author

Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities.

Cancer·2026
Same author

Upregulation of an Epithelial miRNA Is Associated with Immune Evasion in Progressive Bronchial Premalignant Lesions.

Cancer immunology research·2026
Same author

Targeting NHEJ activates STING signaling through MYC degradation to boost antitumor immunity in SCLC.

Nature communications·2026
Same author

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Related Experiment Video

Updated: Apr 6, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

489

Update in Lung Cancer 2014.

Avrum Spira1, Balazs Halmos2, Charles A Powell3

  • 11 Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts.

American Journal of Respiratory and Critical Care Medicine
|August 1, 2015
PubMed
Summary

Recent lung cancer research shows improved outcomes through targeted therapies, immunotherapy, and screening. These advances offer hope for reducing global lung cancer deaths.

Keywords:
biomarkerschest computed tomography screeninglung cancerlung immunotherapytargeted therapy

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K
A Permanent Window for Investigating Cancer Metastasis to the Lung
07:06

A Permanent Window for Investigating Cancer Metastasis to the Lung

Published on: July 1, 2021

5.8K

Related Experiment Videos

Last Updated: Apr 6, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

489
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K
A Permanent Window for Investigating Cancer Metastasis to the Lung
07:06

A Permanent Window for Investigating Cancer Metastasis to the Lung

Published on: July 1, 2021

5.8K

Area of Science:

  • Oncology
  • Pulmonology
  • Genetics

Background:

  • Lung cancer remains the leading cause of cancer mortality globally.
  • Significant advancements in research and clinical care have occurred in the last two years.
  • These developments offer potential for improved patient outcomes and reduced mortality.

Purpose of the Study:

  • To review recent progress in lung cancer research and clinical care.
  • To highlight key advancements in targeted therapy, immunotherapy, and screening.
  • To discuss future challenges in the field of lung cancer.

Main Methods:

  • Review of recent scientific literature and clinical trial data.
  • Analysis of emerging molecular targets for personalized medicine.
  • Evaluation of progress in lung tumor immunotherapy and screening protocols.

Main Results:

  • Identification of novel molecular targets for personalized targeted therapy.
  • Validation of molecular signatures for assessing lung cancer risk in smokers.
  • Progress in lung tumor immunotherapy and implementation of screening programs.

Conclusions:

  • Recent advancements have significantly improved lung cancer outcomes.
  • Personalized therapies, immunotherapy, and screening are key areas of progress.
  • Continued research is essential to address future challenges and further reduce lung cancer deaths.